Executive Employment AgreementExecutive Employment Agreement • December 18th, 2015 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
ARIAD Pharmaceuticals, Inc. (the “Company”), a Delaware corporation, and Paris Panayiotopoulos (the “Employee”), an individual, enter into this Executive Employment Agreement as of December 16, 2015 (the “Agreement”).
FORM OF STOCK OPTION AGREEMENT GOVERNED BY THE TERMS, CONDITIONS AND LIMITATIONS OF THE ARIAD PHARMACEUTICALS, INC. 2014 LONG-TERM INCENTIVE PLANForm of Stock Option Agreement • December 18th, 2015 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances)
This Stock Option Agreement (this “Option Agreement”) certifies that the Board of Directors of ARIAD Pharmaceuticals, Inc. (the “Company”) has granted an option (the “Option”) to purchase shares of the Company’s common stock, $.001 par value per share (the “Shares”), that is governed by the terms, conditions and limitations of the ARIAD Pharmaceuticals, Inc. 2014 Long-Term Incentive Plan (the “2014 Plan”), as follows:
FORM OF RESTRICTED STOCK UNIT AGREEMENT GOVERNED BY THE TERMS, CONDITIONS AND LIMITATIONS OF THE ARIAD PHARMACEUTICALS, INC. 2014 LONG-TERM INCENTIVE PLANRestricted Stock Unit Agreement • December 18th, 2015 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances)
This Restricted Stock Unit Agreement (this “Restricted Stock Unit Agreement”) certifies that the Board of Directors of ARIAD Pharmaceuticals, Inc. (the “Company”) has granted an unvested right to receive shares of Common Stock, $.001 par value per share, of the Company (the “RSUs”), payable as soon as administratively feasible following each of the following vesting dates, assuming the Participant is then employed by the Company, that is governed by the terms, conditions and limitations of the ARIAD Pharmaceuticals, Inc. 2014 Long-Term Incentive Plan (the “2014 Plan”), as follows:
